Intravenous EDTA (ethylene diamine tetra-acetic acid), with Vitamin C. Initially introduced in 1914 to remove mercury from coal miners, the U.S. Food and Drug Administration has approved the use of chelation therapy with EDTA for treatment.
EDTA chelation therapy is primarily prescribed for the removal of heavy (and light) metals, especially mercury, lead, aluminum, radioactive isotopes, as well as plaque build-up on artery walls and heart capillaries, de-calcification of the pituitary gland (from fluoride), and more. These unwanted minerals interfere with enzyme function, nerve and brain function, heart and lung function, skin health, hair growth, immunities, mood, and tend to promote free radical damage.
Potential benefits of IV chelation:
On very rare occasion, some people, when first receiving intravenous infusions, have experienced the so-called Herxheimer Effect, a result of infusions very efficiently neutralizing pathogens and occasionally stimulating immunities too fast for the body to dispose toxins through normal elimination channels. This forces the body to utilize the secondary eliminative organs: lungs, sinuses, skin, and more. Experiences that may feel like a slight cold or the flu, loose bowels, shivers, etc. The skin may eliminate stored toxins, perhaps producing minor, temporary skin eruptions – all part of elimination of toxins that cause premature aging and skin problems, and are considered beneficial reactions, in that the immune system has been activated, and is working to heal from pathogens and toxins.